Leveraging Whole Genome Sequencing Using the TrueMRD Platform for Precision Cancer Monitoring

• The TrueMRD Platform uses whole-genome sequencing on primary baseline and every subsequent sample
• A.I. model analyzes thousands of genomic signals to create a patient-specific signature
• The TrueMRD Platform enables monitoring of patient-specific cancer evolution over time

Speakers:

Bill Bulman

Medical Director, Pulmonology

Veracyte